About 1 result found for searched term "XL092" (0.127 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M11240 | XL092 | TAM Receptor |
| JUN04542; Zanzalintinib | ||
| XL092 is an orally active, ATP-competitive inhibitor of multireceptor tyrosine kinases (RTKs), including MET, VEGFR2, AXL and MER, with IC50 values of 15 nM, 1.6 nM, 3.4 nM and 7.2 nM in cell analysis, respectively. XL092 has antitumor activity. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
